Tags |
|
|
Links |
|
|
Top Articles - Grasping The Language Of Investment
Fixed interest investments
These are investments where the income is a fixed amount, at least for the time being. Usually the capital value is also fixed, although in some cases it can change, too. However, either income or capital are fixed and in many cases both.
Equities
These are i
These are investments where the income is a fixed amount, at least for the time being. Usually the capital value is also fixed, although in some cases it can change, too. However, either income or capital are fixed and in many cases both.
Equities
These are i
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nvestments in ordinary shares of companies, where both the income and the capital can vary up or down.
They can be bought and sold on a stock exchange and they participate in profits (after any preference dividend is paid) and receive dividends, usually paid half yearly.
Shares have a par value usua
Shares have a par value usua
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ly ?1 or 50p but this bears no relationship to their market value and can be ignored.
Fixed interest versus equities
All statistics show that in the long run, due to capital growth, equities beat fixed interest by a big margin, whereas fixed interest may not even beat inflation
Here is anoth
Fixed interest versus equities
All statistics show that in the long run, due to capital growth, equities beat fixed interest by a big margin, whereas fixed interest may not even beat inflation
Here is anoth
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
er comparison. If you invested ?1,000 in 1973, 20 years later, in 1993, it would have grown to:
- building society (average) ?43,000
- shares (FTSE 100) ?297,000
Even after allowing for inflation, the equity investment would have risen to ?56,000, whereas the building society would not have kept
- building society (average) ?43,000
- shares (FTSE 100) ?297,000
Even after allowing for inflation, the equity investment would have risen to ?56,000, whereas the building society would not have kept
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ace with inflation and would have fallen to ?8,700.
Although the income on equities is less than on fixed interest to start with, it catches up and passes it in the long run. Over the past 30 years or so, income from equities has on average doubled every seven years
But to achieve the best returns on
Although the income on equities is less than on fixed interest to start with, it catches up and passes it in the long run. Over the past 30 years or so, income from equities has on average doubled every seven years
But to achieve the best returns on
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
equities it is necessary to have flexibility in the timing of both buying and selling and an ability to remain invested for the long term say five years at least.
Risk
The more you have invested and the longer you can leave it alone, the more risk you can afford to take with some of it to ach
Risk
The more you have invested and the longer you can leave it alone, the more risk you can afford to take with some of it to ach
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
eve a higher reward. The most important thing is to recognise the existence of risk and to take appropriate steps.
Spread your investments over a number of different categories, having perhaps more than one investment in each category. Consider pooled investments such as unit trusts
In this connection
Spread your investments over a number of different categories, having perhaps more than one investment in each category. Consider pooled investments such as unit trusts
In this connection
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
, some advisers suggest that you should take into account your income from earnings (or from your pension if you are retired), which they capitalise and call your lifetime capital. The relative steadiness of this income can mean that you can take more risk with your investments.
Always look at the down
Always look at the down
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ide risk of each investment and decide whether you are happy with it. However, to achieve higher returns in the long run, you need to take some risk.
Shares have three opportunities/risks:
- the individual company,
- the market sector (such as stores, banks); and
- the overall market.
The v
Shares have three opportunities/risks:
- the individual company,
- the market sector (such as stores, banks); and
- the overall market.
The v
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
olatility of individual shares has increased significantly in recent years and the potential to lose money is something like three times as great as 30 40 years ago. This applies in particular to shares in the FTSE 100 index (smaller companies are less volatile). In very recent times this increased vola
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ility is due to the Internet linked companies.
Events in the lifecycle of shares
New issues
New shares sometimes come to the market as a result of de nationalisation and de mutualisation but any company coming to the market for the first time is a new issue. Application forms are printe
Events in the lifecycle of shares
New issues
New shares sometimes come to the market as a result of de nationalisation and de mutualisation but any company coming to the market for the first time is a new issue. Application forms are printe
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
in newspapers and are available on request. You fill in the form and send it off with a cheque.
You may not get all the shares you ask for. Some people apply for more than they expect to get. Stags are people who aim for a quick profit, applying for a large number of shares with the intention of selli
You may not get all the shares you ask for. Some people apply for more than they expect to get. Stags are people who aim for a quick profit, applying for a large number of shares with the intention of selli
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ng them as soon as they are received.
There is no commission or stamp duty payable on new issues and the full amount may be payable in instalments.
Rights issues
This is where a company raises further capital by offering existing shareholders the right to apply for more shares. The price is us
There is no commission or stamp duty payable on new issues and the full amount may be payable in instalments.
Rights issues
This is where a company raises further capital by offering existing shareholders the right to apply for more shares. The price is us
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ally set below the current market price so that the rights themselves have a market value.
Shareholders can decide whether to take up their rights, so investing more money in the company, or to sell them. Those taking no action usually have the rights sold for them.
There is a third way, called tail s
There is a third way, called tail s
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
wallowing, which is particularly appropriate if your investment is in a PEP or ISA. If you wish to take up the rights but have insufficient cash in the account, you can sell enough rights to bring your cash available up to the amount required for the remaining rights.
Bonus issues
This is a mis
Bonus issues
This is a mis
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
omer there is no bonus! A better term is scrip issues (or capitalisation issues) and it is where existing shares are subdivided into, say, two new shares, thus doubling the number of shares and halving their value. No new money passes, the action being taken usually because the share price has risen t
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
o a level which is considered too high for an effective market.
Scrip dividends
This is where companies offer shareholders the opportunity to take new shares instead of a cash dividend. It is a cheap way to invest more money in a company but it complicates capital gains tax calculations. Share
Scrip dividends
This is where companies offer shareholders the opportunity to take new shares instead of a cash dividend. It is a cheap way to invest more money in a company but it complicates capital gains tax calculations. Share
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
buy backs
A company sometimes buys back shares, usually because it has surplus cash which cannot be invested more profitably elsewhere. The effect should be an increase in the share price.
Take over bids
From time to time one company will attempt to take over another by offering an attractive
A company sometimes buys back shares, usually because it has surplus cash which cannot be invested more profitably elsewhere. The effect should be an increase in the share price.
Take over bids
From time to time one company will attempt to take over another by offering an attractive
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
price for the shares. It is worth waiting for a competitive offer, even if the directors recommend acceptance. Newspapers and investment magazines will comment on the offer.
If the buying company is successful it can force the purchase against reluctant sellers.
Receivership and liquidation
If
If the buying company is successful it can force the purchase against reluctant sellers.
Receivership and liquidation
If
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
a company fails to pay debts a lender of money to it can appoint a receiver to manage its affairs (or have one appointed by the creditors) or the company can be put into liquidation. In either case, it is unlikely that the equity shareholders will get much, if anything they are at the end of the queue
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102171/toparticles-Grasping-The-Language-Of-Investment.html">Grasping The Language Of Investment</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102171/toparticles-Grasping-The-Language-Of-Investment.html]Grasping The Language Of Investment[/url]
Related Articles:
Real Estate Is Your Friend, Invest in It
Online Business and Entrepreneurialism, Why Are We Being Mislead?
6 Tips to Significantly Improve Your E-mail Response
Bookmark it:
|